Vanguard Group Inc Gossamer Bio, Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 11,760,251 shares of GOSS stock, worth $11.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,760,251
Previous 11,763,784
0.03%
Holding current value
$11.3 Million
Previous $13.9 Million
23.75%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding GOSS
# of Institutions
101Shares Held
175MCall Options Held
453KPut Options Held
543K-
Nea Management Company, LLC Timonium, MD18.1MShares$17.4 Million1.54% of portfolio
-
Artal Group S.A. Luxembourg, N413.3MShares$12.8 Million0.76% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$8.82 Million1.91% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$7.73 Million4.25% of portfolio
-
Palo Alto Investors LP Palo Alto, CA6.28MShares$6.03 Million0.72% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $90.2M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...